跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,668 条关于
“Antares Pharma”
全部
9,668
临床试验
4,137
药物
1,116
机构
1,229
资讯
3,186
去年
Needle-Free Drug Delivery Devices Market Set to Reach $5+ Billion by 2035
9个月前
TransCode Therapeutics Appoints Jack E. Stover to Board of Directors to Strengthen RNA and Immuno-Oncology Leadership
3年前
Lipocine Pivots to CNS Disorders with Oral Neuroactive Steroid Pipeline
去年
Smart Drug Delivery Systems Market Poised for 17% Growth as Chronic Disease Management Evolves
2个月前
Antares Therapeutics Signs Potential $1.9 Billion Deal with Novartis to Target Undruggable Oncology Proteins
去年
Antares Therapeutics Launches with $177 Million Series A to Advance First-in-Class Cancer Precision Medicines
去年
Pierre Fabre Acquires Global Rights to Next-Generation EGFR Inhibitors for NSCLC Treatment
7个月前
Sana Biotechnology Appoints Brian Piper as CFO Ahead of Key Clinical Data Readouts
上个月
Royalty Pharma and Zealand Pharma enter $100 million rusfertide funding agreement
去年
FDA Approves Verona Pharma's Ohtuvayre (ensifentrine) for COPD Maintenance
第 1 页,共 319 页
上一页
下一页